myelodysplastic syndrome with ring sideroblasts
myelodysplastic syndrome with ring sideroblasts
Explore linked clinical trials. Standard reference: MONDO:00191572 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute erythroid leukemia, acute megakaryoblastic leukemia, acute myeloid leukemia, anemia, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with ring sideroblasts, myelodysplastic syndrome with single lineage dysplasia, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-07 | NCT00392353 | |
| Biocollection in MyeloDysplastic Syndrome (P-MDS) | Chromosome Aberrations, Hemic and Lymphatic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute myeloid leukemia with multilineage dysplasia, bone marrow disorder, hematologic disorder, myelodysplastic syndrome, myelodysplastic syndrome associated with isolated del(5q), myelodysplastic syndrome with ring sideroblasts | Recruiting | Not applicable | 2026-06-25 | NCT04869683 |